Healthcare provider profile · identity verified

Robert J Rhodes, MD

Family Practice · CENTENNIAL, CO · NPI 1689894412

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	179
Levothyroxine Sodium	Levothyroxine Sodium	382	105
Simvastatin	Simvastatin	338	97
Lisinopril	Lisinopril	262	76
Tamsulosin Hcl	Tamsulosin Hcl	236	73
Losartan Potassium	Losartan Potassium	207	57
Metformin Hcl	Metformin Hcl	197	60
Amlodipine Besylate	Amlodipine Besylate	196	55
Omeprazole	Omeprazole	178	59
Gabapentin	Gabapentin	170	50
Pradaxa	Dabigatran Etexilate Mesylate	168	48
Rosuvastatin Calcium	Rosuvastatin Calcium	157	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	138	40
Metoprolol Tartrate	Metoprolol Tartrate	137	41
Hydrochlorothiazide	Hydrochlorothiazide	113	33
Furosemide	Furosemide	108	42
Alendronate Sodium	Alendronate Sodium	101	38
Atenolol	Atenolol	97	27
Trazodone Hcl	Trazodone Hcl	91	25
Glipizide	Glipizide	86	25
Albuterol Sulfate Hfa	Albuterol Sulfate	82	43
Warfarin Sodium	Warfarin Sodium	78	18
Allopurinol	Allopurinol	76	21
Meloxicam	Meloxicam	73	34
Potassium Chloride	Potassium Chloride	72	22
Famotidine	Famotidine	71	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	17
Oxycodone Hcl	Oxycodone Hcl	63	11
Metoprolol Succinate	Metoprolol Succinate	59	22
Sertraline Hcl	Sertraline Hcl	59	22
Pantoprazole Sodium	Pantoprazole Sodium	58	17
Finasteride	Finasteride	57	17
Mirtazapine	Mirtazapine	51	17
Tramadol Hcl	Tramadol Hcl	50	26
Acyclovir	Acyclovir	48	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	48	48
Jardiance	Empagliflozin	46	14
Metformin Hcl Er	Metformin Hcl	46	14
Bupropion Xl	Bupropion Hcl	44	14
Clopidogrel	Clopidogrel Bisulfate	44	13
Doxazosin Mesylate	Doxazosin Mesylate	43	12
Fluticasone Propionate	Fluticasone Propionate	43	16
Wixela Inhub	Fluticasone Propion/Salmeterol	42	18
Ezetimibe	Ezetimibe	41	16
Spironolactone	Spironolactone	41	12
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Duloxetine Hcl	Duloxetine Hcl	36	15
Prednisone	Prednisone	35	24
Venlafaxine Hcl Er	Venlafaxine Hcl	34	12
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	12
Carvedilol	Carvedilol	32	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Humulin N	Insulin Nph Human Isophane	30	11
Lorazepam	Lorazepam	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	27
Cephalexin	Cephalexin	28	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	28	25
Triamcinolone Acetonide	Triamcinolone Acetonide	27	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	26	26
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Tadalafil	Tadalafil	25	suppressed
Trospium Chloride	Trospium Chloride	25	suppressed
Colchicine	Colchicine	24	suppressed
Eliquis	Apixaban	21	suppressed
Digoxin	Digoxin	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Alvesco	Ciclesonide	18	suppressed
Baclofen	Baclofen	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Alprazolam	Alprazolam	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	13
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Celecoxib	Celecoxib	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Nystatin	Nystatin	12	suppressed
Azithromycin	Azithromycin	11	11
Humulin R	Insulin Regular, Human	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error